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82 The Journal of Thoracic and Cardiobjective: Mesenteric ischemia is a rare but potentially devastating complication of
ardiac surgery with cardiopulmonary bypass. We hypothesized that alterations in
itogen-activated protein kinase pathways contribute to mesenteric microcircula-
ory dysfunction resulting from cardiopulmonary bypass.
ethods: Pigs underwent cardiopulmonary bypass (n  6) for 90 minutes and
ostbypass reperfusion for 180 minutes. Sham operations (n  6) were performed
n controls. Mesenteric tissue was harvested before bypass and after postbypass
eperfusion. Microvascular contraction to phenylephrine and vasopressin was ex-
mined by videomicroscopy. Contractile responses with inhibition of the extracel-
ular regulated kinase 1/2 (ERK1/2) pathway by PD98059 (30 mol/L) and p38
inase inhibition by SB203580 (1 mol/L) also were determined. Activated forms
f ERK1/2 and p38 kinase were measured by Western blot. ERK1/2 and p38 activity
ere localized in mesenteric tissue by immunohistochemistry.
esults: Contractile responses to phenylephrine were increased at 180 minutes after
ardiopulmonary bypass (49.7%  5.5%, P  .01), whereas contraction to
asopressin was unchanged. ERK1/2 pathway inhibition reduced contractile re-
ponses to phenylephrine at baseline and 180 minutes after bypass (both P  .01)
ut had no effect on contraction to vasopressin. p38 Kinase inhibition decreased the
ontractile responses to vasopressin at baseline and 180 minutes after bypass (both
 .01) but did not alter the contractile response to phenylephrine. Activated
RK1/2 levels were increased by more than 40% at 180 minutes after bypass (P 
01). Protein levels of activated p38 kinase were not changed. The increased ERK1/2
ctivity was associated with mesenteric arterioles by immunohistochemistry.
onclusions: A differential pattern of mesenteric vasomotor regulation exists after
ardiopulmonary bypass that may contribute to the risk of mesenteric ischemia after
ardiac surgery.
esenteric ischemia is a rare but potentially devastating complication of
cardiac surgery with cardiopulmonary bypass (CPB). Although mesenteric
ischemia occurs in fewer than 1% of cardiac surgical procedures, the mor-
ality rate exceeds 50% in most reported series.1,2 Previously, we3 have shown in a
orcine model of CPB that mesenteric arterioles have an increased contractile response
o phenylephrine after CPB, suggesting a potential mechanism contributing to decreased
vascular Surgery ● March 2007
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Perfusion and mesenteric ischemia that complicates cardiac
urgery. Alterations in vasomotor regulation involve protein
inase pathways including the mitogen-activated protein ki-
ase (MAPK) pathways. MAPK are serine-threonine pro-
ein kinases that are involved in vasomotor function as well
s vascular permeability, cytokine production, and reperfu-
ion injury. Three major MAPK families have been identi-
ed as the extracellular signal-regulated kinases 1/2 (ERK1/
), c-Jun NH(2)-terminal protein kinases, and p38 kinases,
hich have established roles in cardiovascular signal trans-
uction cascades.4 In a previous study of patients undergo-
ng cardiac surgery, we5 demonstrated that CPB resulted in
ecreased contraction of peripheral, skeletal muscle arte-
ioles to phenylephrine and vasopressin. The impaired con-
ractile responses of peripheral microvessels to phenyleph-
ine were shown to be due to diminished ERK1/2 activity,
hereas reduced p38 activity was associated with attenu-
ted contraction to vasopressin.5 Thus, vasopressors used to
reat hypotension after cardiac surgery, such as phenyleph-
ine and vasopressin, appear to involve different biochem-
cal pathways that regulate the vasomotor function of mi-
rovessels. In addition, these studies provided evidence that
here are specific vasomotor responses to CPB in each organ
ystem, and that these changes in vascular reactivity may be
ediated by alterations in MAPK pathways. We hypothe-
ized that CPB increases the mesenteric vasomotor contrac-
Figure 1. Mesenteric contraction to phenylephrine is increased
after CPB. Arterioles from the mesenteric system showed in-
creased contraction to phenylephrine after CPB compared with
baseline (49.7%  5.5%; *P < .01). After sham procedures,
contractile responses to phenylephrine were reduced versus the
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
ERK1/2 extracellular regulated kinase 1/2
MAPK mitogen-activated protein kinasebaseline (37.0%  5.1%; *P < .01).
The Journal of Thoracicile response to vasopressors through alterations in MAPK
athways.
aterials and Methods
nimals and Experimental Design
nimals were housed individually and provided with laboratory
how and water ad libitum. All experiments were approved by the
eth Israel Deaconess Medical Center Animal Care and Use
ommittee (Institutional Animal Care and Use Committee).
Pigs (35-40 kg) were divided randomly into sham (n  6) and
PB (n  6) groups. Animals in the CPB group underwent CPB
or 90 minutes. After 5 minutes of CPB, the aorta was cross-
lamped and cold potassium cardioplegic solution was adminis-
ered for 80 minutes of cardioplegic arrest. The crossclamp then
as removed, and the myocardium was reperfused for 5 minutes
n CPB, followed by a period of post-CPB reperfusion for 180
inutes. The sham group was subjected to sternotomy and hepa-
inization only.
urgical Procedure
igs were anesthetized with intramuscular ketamine hydrochloride
20 mg/kg) and isoflurane gas by endotracheal intubation and
echanical ventilation. Arterial pressure, heart rate, electrocardio-
ram, oxygen saturation, arterial blood gases, and temperature
Figure 2. Contractile responses of mesenteric arterioles to phen-
ylephrine are in part dependent on ERK1/2 activity at baseline.
Blockade of the ERK1/2 pathway with PD98059 reduced mesen-
teric microvessel contraction to phenylephrine at baseline in
both the sham and CPB groups (31%  4.1% and 52%  9.1%,
respectively; *P < .01). Blockade of the p38 pathway with
SB203580 had no effect on phenylephrine-induced contraction in
either the sham or CPB groups at baseline.
and Cardiovascular Surgery ● Volume 133, Number 3 683
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CSPere monitored. The pericardial sac was opened through a median
ternotomy. Pigs were given intravenous heparin (300 units/kg)
nd cannulated via the distal ascending aorta and the right atrium.
PB was initiated with a kaolin activated clotting time of more
han 480 seconds, which was maintained. The proximal aorta was
rossclamped, and cold crystalloid cardioplegic solution was in-
used into the aortic root. An initial 300 mL of cold high-potassium
ardioplegic solution (0°C-4°C, 25 mmol/L K) was administered
ollowed by 150 mL of cold low-potassium cardioplegic solution
0°C-4°C, 12 mmol/L K) each 15 minutes.
issue Collection
amples of mesenteric tissue were harvested in both groups at
aseline and at 180 minutes of post-CPB reperfusion. The mesen-
eric tissue was snap frozen in liquid nitrogen and stored at80°C
or molecular analysis or fixed in 4% formaldehyde for immuno-
istochemical analysis.
n Vitro Assessment of Mesenteric Microvascular
esponses
esenteric arterioles (80-150 m in diameter and 1-2 mm in
Figure 3. ERK1/2 inhibition prevents the increased contraction of
mesenteric arterioles to phenylephrine after CPB. PD98059 inhi-
bition of the ERK1/2 pathway attenuated the increased contrac-
tion to phenylephrine post-CPB (62%  9.1%, *P < .01). The
contraction to phenylephrine at 180 minutes was decreased com-
pared with baseline in the sham group and was not further
reduced by ERK1/2 blockade. Inhibition of p38 activity with
SB203580 had no effect on contraction to phenylephrine in either
the sham or CPB groups.ength) were dissected from the surrounding tissue with a 40 m
84 The Journal of Thoracic and Cardiovascular Surgery ● Marcicroscope and examined in isolated organ chambers as previ-
usly described.5 Contractile responses were examined to phen-
lephrine (1-100 mol/L) and vasopressin (1 nmol/L- mol/L) in
oth the presence and absence of the p38 kinase inhibitor
B203580 (1 mol/L) or the ERK 1/2 inhibitor PD98059 (30
mol/L). Responses were recorded as percent contraction of the
aseline diameter.
estern Blot Analysis
otal lysate from mesenteric tissue was obtained, separated by sodium
odecylsulfate–polyacrylamide gel electrophoresis, and transferred to
embranes as previously described.5 Membranes were incubated
ith anti-phospho-p44/p42 (ERK1/2) MAPK (New England Biolabs,
everly, Mass) or anti-phospho-p38 (Santa Cruz Biotechnology,
anta Cruz, Calif) antibody for 2 hours, followed by the appropriate
econdary antibody conjugated to horseradish peroxidase.
mmunohistochemistry
esenteric tissues were fixed, embedded in paraffin, sectioned
5 m), and mounted on glass slides. Immunostaining was per-
ormed as previously described.5 The sections were incubated with
ither the polyclonal rabbit anti-phospho-ERK1/2 (New England
iolabs) or anti-phospho-p38 antibody (Santa Cruz Biotechnol-
gy), followed by biotin-conjugated antirabbit immunoglobulin G
econdary antibody and avidin-biotin-peroxidase complex (Santa
ruz Biotechnology).
tatistical Analysis
alues are shown as mean  SEM. Statistical analyses were
erformed by 2-factor analysis of variance for repeated measures
r t test as appropriate.
esults
o Differences in Hemodynamics, Arrhythmia,
emperature, or Arterial Blood Gas
o significant differences were observed in heart rate or
Figure 4. Contraction to vasopressin was not changed in mesen-
teric microvessels after CPB. The mesenteric vasomotor re-
sponses to vasopressin were similar to the baseline after 180
minutes in both the sham and CPB groups.ean arterial pressure between the sham and CPB groups.
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Pncidence of arrhythmia, core temperature, and arterial
lood gas measurements were not significantly different
etween groups (data not shown).
ncreased Mesenteric Microvascular Contraction to
henylephrine After CPB, Which Is Prevented by
RK1/2 Inhibition
esenteric arterioles showed increased contractile re-
ponses to phenylephrine after CPB compared with baseline
49.7% 5.5%; P .01). In the sham group, contraction to
henylephrine was reduced after the sham procedure compared
ith baseline (37.0%  5.1%; P  .01; Figure 1). Inhibition
f the ERK1/2 pathway with PD98059 reduced the contrac-
ion to phenylephrine at baseline in both the sham and CPB
roups (31%  4.1% and 52%  9.1%, respectively;
oth P  .01; Figure 2) and prevented the increased con-
ractile responses to phenylephrine after CPB (62% 
.1%; P  .01; Figure 3). The already decreased contraction
o phenylephrine at 180 minutes in the sham group was not
urther reduced by ERK1/2 pathway blockade. p38 Inhibi-
Figure 5. Contractile responses of mesenteric arterioles to vaso-
pressin are in part dependent on the p38 pathway at baseline.
Inhibition of p38 pathway activity with SB203580 decreased con-
traction to vasopressin at baseline in both sham and CPB groups
(27%  4.3% and 25%  2.5%, respectively; *P < .01). ERK1/2
blockade with PD98059 showed no change in contraction to
vasopressin in either sham or CPB groups at baseline.ion with SB203580 had no effect on contractile responses a
The Journal of Thoracico phenylephrine in either the sham or CPB group (Figures
 and 3).
ontractile Responses to Vasopressin Are Unchanged
fter CPB and Reduced by p38 Inhibition
ontractile responses to vasopressin were unchanged from
aseline after 180 minutes in both the sham and CPB groups
Figure 4). p38 Pathway blockade with SB203580 reduced
ontractile responses to vasopressin at baseline in both sham
nd CPB groups (27%  4.3% and 25%  2.5%,
espectively; both P  .01; Figure 5), as well as after 180
inutes in the sham and CPB groups (29%  3.6% and
41%  3.5%, respectively; both P  .01; Figure 6).
RK1/2 inhibition resulted in no change in contraction to
asopressin in either the sham or CPB groups at baseline
nd after 180 minutes (Figures 5 and 6).
PB Increases ERK1/2 Activation, Whereas p38
ctivity Is Unchanged
ctivated ERK1/2 levels were increased by more than 40%
igure 6. Mesenteric microvessel contraction to vasopressin is
n part dependent on p38 activity after CPB. After 180 minutes in
he sham and CPB groups, p38 inhibition with SB203580 reduced
ontraction to vasopressin (29%  3.6% and 41%  3.5%,
espectively; *P < .01). PD98059 inhibition of the ERK1/2 pathway
roduced no change in contraction to vasopressin in either sham
r CPB groups after 180 minutes.fter CPB compared with baseline. In the sham group,
and Cardiovascular Surgery ● Volume 133, Number 3 685
E
c
i
C
I
A
I
E
c
p
p
D
I
m
c
r
v
t
p
t
t
e
k
m
p
a
w
i
c
a
o
u
o
a
a
o
v
r
F
o
i
w
b
d
w
b
F
o
t
i
Cardiopulmonary Support and Physiology Khan et al
6
CSPRK1/2 levels were slightly decreased after the sham pro-
edure, although the difference was not statistically signif-
cant. Levels of p38 were unchanged in both the sham and
PB groups (Figures 7 and 8).
ncreased Activated ERK1/2 Localizes to Mesenteric
rterioles
n histologic sections of mesenteric tissue, activated
RK1/2 localized to arterioles and was increased after CPB
ompared with controls (Figure 9). Staining of activated
38 in mesenteric arterioles was unchanged after CPB com-
ared with baseline (data not shown).
iscussion
n our study of the mesenteric microvasculature in a pig
odel of CPB, the main findings are as follows: (1) in-
reased contraction of mesenteric arterioles to phenyleph-
ine after CPB and no difference in the response to
asopressin; (2) decreased contractile response of mesen-
eric arterioles to phenylephrine by inhibition of the ERK1/2
athway; (3) reduction in mesenteric microvessel contrac-
ion to vasopressin by p38 kinase blockade; and (4) eleva-
ion in activated ERK1/2 after CPB that localizes to mes-
nteric arterioles and no change in levels of activated p38
inase. On the basis of these results, we conclude that
esenteric microvascular contraction to phenylephrine is in
art dependent on ERK1/2 and increased after CPB through
igure 7. ERK1/2 activity is increased after CPB, whereas levels
f activated p38 are unchanged. Representative Western blot
mages of activated ERK1/2 and p38. Levels of activated ERK1/2
ere increased by more than 40% after CPB compared with
aseline (BL). In the sham group, there was a trend toward
ecreased ERK1/2 activity after the sham procedure compared
ith baseline (BL). Levels of activated p38 were unchanged in
oth the CPB and sham groups.mechanism that involves activation of the ERK1/2 path- a
86 The Journal of Thoracic and Cardiovascular Surgery ● Marcay. The mesenteric contractile response to vasopressin
nvolves p38 kinase and is unchanged after CPB.
Mesenteric ischemia is an uncommon but highly morbid
omplication of cardiac surgery with CPB and has been
ssociated with patient risk factors including 3-vessel cor-
nary artery disease, peripheral vascular disease, renal fail-
re, and diabetes mellitus. Operative risk factors for devel-
pment of mesenteric ischemia include duration of CPB and
ortic crossclamp time, use of an intra-aortic balloon pump,
nd the use of inotropic and vasopressor support.1,6 The use
f vasopressor agents during and after CPB appears to have
ariable effects on different organ systems. In a study of
egional perfusion in a pig model of CPB, phenylephrine
igure 8. ERK1/2 activity is increased after CPB, whereas levels
f activated p38 are unchanged. Histogram showing quantifica-
ion of Western blot analysis of activated ERK1/2 and p38 levels
n the sham and CPB groups (*P < .01).dministered to treat hypotension during CPB raised the
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Pystemic blood pressure with increased vascular resistances
n the mesenteric and renal vascular beds, while cerebral
nd femoral vascular resistances remained unchanged. This
ncrease in mesenteric vascular resistance resulted in de-
reased perfusion, which was shown by reduced radioactive
icrosphere blood flow measurements.7 In studies from our
aboratory, we found similar differences in vasomotor re-
ponses to CPB. In peripheral arterioles harvested from
keletal muscle of cardiac surgery patients before and after
PB, we5 found that the contractile responses to phenyl-
phrine and vasopressin were reduced after CPB. In con-
rast, using a pig model of CPB with cardioplegic arrest,
e3 observed that the contraction of mesenteric arterioles to
henylephrine was greater after CPB than before CPB.
imilarly, an increased contractile response of mesenteric
rteries to phenylephrine after CPB was shown in an animal
odel of partial CPB.8 Thus, the differential contractile
esponses to vasopressor agents used to treat hypotension
fter CPB likely contribute to mesenteric hypoperfusion and
schemia, inasmuch as there is reduced contraction in cer-
ain vascular territories as in skeletal muscle while the
esenteric system demonstrates greater vasoconstriction.
CPB has been suggested to cause mesenteric hypoperfu-
ion associated with local changes in vasoconstrictor and
asodilator neurohumoral regulation. Gut mucosal hypoper-
usion has been demonstrated in both animal models and
atients undergoing CPB.9,10 Recently, poly(adenosine 5=-
iphosphate-ribose) and nitric oxide deficiency have been
hown to be involved in mesenteric vascular dysregulation
fter CPB.11,12 MAPK pathways also have been suggested
o mediate vasomotor responses in mesenteric resistance
essels. The ERK1/2 pathway has been demonstrated to
ediate the contractile response of mesenteric arterioles to
ngiotensin II,13,14 which has been proposed as a contribu-
or to decreased mesenteric perfusion during and after
PB.15 In addition, p38 and ERK1/2 have been implicated e
The Journal of Thoracicn the molecular pathway of contractile response of mesen-
eric resistance vessels to norepinephrine.16,17 p38 Has been
hown to mediate thromboxane-induced contraction of mes-
nteric resistance arteries.18 In a study of peripheral vaso-
otor function in patients after cardiac surgery with CPB,
e5 demonstrated that MAPK pathways in part mediate a
ecrease in contractile responses to phenylephrine and va-
opressin that were associated with reductions in ERK1/2
nd p38 activity. The results of the present study are con-
istent with these previous findings in that changes in
APK activity contribute to vasomotor dysfunction after
PB. However, in this study, although ERK1/2 and p38
ere shown to mediate contractile responses to phenyleph-
ine and vasopressin, respectively, ERK1/2 activity was
levated and associated with increased contraction to phen-
lephrine after CPB, whereas p38 activation was unchanged
nd we observed no increase in contraction to vasopressin
fter CPB. The decrease in contraction to phenylephrine in
he sham group at 180 minutes is worth mention. In accor-
ance with this finding, we observed a trend of decreased
RK1/2 activity in the sham group at 180 minutes. The
rend of diminished ERK1/2 activity and reduced mesen-
eric contraction to phenylephrine likely involved an effect
f the isoflurane gas general anesthesia. Isoflurane and
evoflurane have been associated with inhibition of ERK1/
-mediated vascular smooth muscle contraction.19,20
The limitations of our study include the operative tech-
ique, the pharmacologic conditions, and the timing of
essel harvest. First, our CPB protocol was under normo-
hermia, whereas many clinical cardiac surgical procedures
nvolve CPB with some degree of hypothermia. This cer-
ainly may have had an impact on the vascular reactivity of
he mesenteric circulation. In addition, in hypothermic CPB
he process of cooling and rewarming per se may alter
ascular regulation owing to the release of circulating cat-
Figure 9. Activated ERK1/2 localizes to
mesenteric arterioles, and is increased
after CPB. Representative histologic
sections showing mesenteric arte-
rioles at baseline (left), post-CPB con-
trol stained with secondary antibody
(2° Ab only; center), and after CPB
(right). Staining of activated ERK1/2 is
demonstrated in the mesenteric arte-
rioles and is increased after CPB com-
pared with baseline and the post-CPB
control.cholamines and other neurohumoral substances that can
and Cardiovascular Surgery ● Volume 133, Number 3 687
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CSPffect adrenergic receptor function and the regulation of
ther signaling pathways. This process could conceivably
urther exacerbate the potential for mesenteric ischemia.
lso, we wanted to examine the mesenteric vascular effects
n a clinically relevant model, so we used a model of CPB
ith cardioplegic arrest. Although unlikely, this may have
nfluenced the results compared with what would have been
bserved with CPB alone. Next, receptor signaling may be
ffected not only by endogenous catecholamines and other
eurohumoral substances released during CPB, but also by
xogenous vasodilator, vasopressor, and inotropic agents
ommonly used in managing patients having cardiac sur-
ery. Thus, the true “clinical” pharmacologic milieu may be
omewhat different from the “pure” experimental condi-
ions tested in the study. Finally, the time to harvest mes-
nteric vessels in our model was restricted to early in the
eperfusion period at 180 minutes after CPB. In postopera-
ive patients, mesenteric ischemia may develop later in the
ostoperative period, at which time the neurohumoral and
olecular pathways may have a different effect on mesen-
eric vascular reactivity to vasopressor agents.
In conclusion, using a porcine model of CPB to study the
esenteric vasomotor responses to vasopressors, we dem-
nstrated that the contraction to phenylephrine was in-
reased after CPB and in part mediated by ERK1/2, whereas
he contractile response to vasopressin involves the p38
athway and is not increased after CPB. The use of vaso-
ressin as a vasopressor agent in the postoperative period
fter cardiac surgery with CPB may reduce mesenteric
ypoperfusion and the risk of mesenteric ischemia.
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